165 related articles for article (PubMed ID: 6898640)
1. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
Kaneko I; Fearon DT; Austen KF
J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
[No Abstract] [Full Text] [Related]
2. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
Moore FD; Fearon DT; Austen KF
J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
[No Abstract] [Full Text] [Related]
3. [Binding of activated C3b component with complement effector].
Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
[TBL] [Abstract][Full Text] [Related]
5. Multiple effects of a diamidine (propamidine) on complement activation.
Vogt W; Hinsch B; Schmidt G; Von Zabern I
Immunology; 1979 Jan; 36(1):131-7. PubMed ID: 422224
[TBL] [Abstract][Full Text] [Related]
6. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
[TBL] [Abstract][Full Text] [Related]
7. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
9. Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization.
Kaneko I; Kamoshida K; Takahashi S
J Antibiot (Tokyo); 1989 Feb; 42(2):236-41. PubMed ID: 2925515
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
Asghar SS; de Koster A; van der Helm HJ
Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
[TBL] [Abstract][Full Text] [Related]
11. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
12. [Complement, a system of recognition of activation and amplification].
Peltier AP; Kazatchkine MD
Ann Immunol (Paris); 1982; 133C(2):149-54. PubMed ID: 6921958
[No Abstract] [Full Text] [Related]
13. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
[TBL] [Abstract][Full Text] [Related]
14. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
Galebskaia LV; Solovtsova IL; Riumina EV
Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
16. Steady state relations between control proteins regulating the formation of the alternative pathway C3 convertase.
Reeve J; Woo PM
Immunology; 1982 Aug; 46(4):859-66. PubMed ID: 6921154
[TBL] [Abstract][Full Text] [Related]
17. Activation of human complement by heat-killed, human kidney cells grown in cell culture.
Baker PJ; Osofsky SG
J Immunol; 1980 Jan; 124(1):81-6. PubMed ID: 6765971
[No Abstract] [Full Text] [Related]
18. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
[No Abstract] [Full Text] [Related]
19. The human alternative complement pathway: biology and immunopathology of activation and regulation.
Kazatchkine MD; Nydegger UE
Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
[No Abstract] [Full Text] [Related]
20. [Inhibition of formation of complement C5-convertase].
Kozlov LV; Lebedeva TV
Bioorg Khim; 1998 May; 24(5):350-5. PubMed ID: 9661788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
